Replies to post #164872 on Cytodyn Inc (CYDY)

[DonDonDonDon]

Perhaps the older more severe cases were enrolled later in the trial.

My guess is that leronlimab did better in the early days because there were no good treatments and doctors understood little about how to deal with Covid. As the SOC became better and doctors understood more, leronlimab was no longer providing much of a benefit. The data from the trial might have all kinds of warts that shareholders will never know anything about because Nader only releases the cherries. Nader can play that game with shareholders but he can't play that game with the FDA.

[MelsDollars]

I believe the Albert Einstein Israelite hospital in Brazil and their ARO have run seven other covid trials so I am looking forward to their results:

https://trialsitenews.com/albert-einstein-israelite-hospital-in-sao-paulo-brazil-to-lead-two-large-brazilian-phase-3-trials-investigating-leronlimab-for-covid-19/